VivoSeq
Other

Tramadol

0

Pipeline Programs↗

1

Active Trials↗

3

Companies Involved↗

Tramadol is an early-stage landscape with 0 programs across 3 companies. The most active players are Johnson & Johnson, Par Pharmaceutical, Inc., Pfizer.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Johnson & Johnson logo

Johnson & Johnson

0 programs

PreclinicalP

Par Pharmaceutical, Inc.

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

25

clinical trials

Completed23 · 92%
Recruiting1 · 4%
Unknown status1 · 4%

Clinical Trials

Trial Activity

25 trials

Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults
Recruiting·HHaiphong University of Medicine and Pharmacy·Phase 1·NCT07060209·14 enrolled
Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination
Completed·LLaboratorios Silanes S.A. de C.V.·Phase 1·NCT05533073·42 enrolled
A Study Comparing Norspan Patch and Oral Tramadol
Completed·MMundipharma Korea Ltd·Phase 4·NCT01019265·170 enrolled
Tramadol and Pain Sensitization
Completed·UUniversity Hospital, Clermont-Ferrand·Phase 1·NCT00487175·12 enrolled
A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers
Completed·Johnson & Johnson logoJohnson & Johnson·Phase 1·NCT01947920·30 enrolled
Study of Two Tramadol Contramid® OAD 300 mg Controlled-Release Tablets From Two Different Manufacturing Sites Following a 300 mg Dose in Healthy Subjects Under Fasting and Fed Conditions
Completed·LLabopharm Inc.·Phase 1·NCT00834912·36 enrolled
A Randomised Open Controlled Parallel Group Study Comparing Norspan and Tramadol
Completed·MMundipharma AB·Phase 4·NCT00399178·160 enrolled
Use of Tramadol Intraligamentary Injections
Completed·—·N/A·NCT05538052·105 enrolled
Tramadol to Improve Its Detection in Biological Matrices in Anti-doping Controls
Completed·PParc de Salut Mar·Phase 1·NCT05925686·25 enrolled
Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions
Completed·PPar Pharmaceutical, Inc.·Phase 1·NCT00652821·22 enrolled
Comparative Bioavailability Between Two Tramadol Formulations: Study of the Better Controlled Release of a New 200 mg Once A Day (OAD) Formulation Versus Zytram® 200 mg
Completed·LLabopharm Inc.·Phase 1·NCT00911742·26 enrolled
PK PD of the Enantiomers of Tramadol and O-desmethyltramadol in Elderly and Young Subjects
Completed·UUniversité de Montréal·Phase 1·NCT02329561·35 enrolled
A Dose Linearity Study of the Labopharm Formulation of Tramadol HCl/Contramid®, 100 mg, 200 mg and 300 mg After A Single Oral Administration In Fasting Condition, In Healthy Human Volunteers
Completed·LLabopharm Inc.·Phase 1·NCT00834808·27 enrolled
Role of Prophylactic Metoclopramide With Tramadol in Trauma Patients
Completed·UUniversity of Malaya·Phase 2·NCT03383315·191 enrolled
Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets
Completed·Pfizer logoPfizer·Phase 4·NCT03803371·60 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)